The COVID Advisor

Turbo cancer is an anti-vaccination conspiracy theory alleging that people vaccinated against COVID-19, especially with mRNA vaccines, are suffering from a high incidence of fast-developing cancers. Although the idea has been spread by a number of vaccine opponents, including several health professionals, turbo cancer is not supported by cancer research, and there is no evidence that COVID-19 vaccination causes or worsens cancer?? ( wikipedia ) Turbo cancer: what is it and how common is it? Are turbo cancers real? Is turbo cancer dangerous? Is turbo cancer a scam?  In medicine, what is considered factual today may be outdated tomorrow, and vice versa.   ' Misinformation ' thrives on inaccurate facts, but defining what's truly accurate can be complex. Science and research are the cornerstones of reliable information, yet they can be misinterpreted or influenced by bia...

Overview A new COVID-19 variant, identified as NB.1.8.1, has recently emerged and is drawing international attention due to its increasing prevalence, particularly in China, and its detection in the United States and other countries. 1. Emergence and Spread of NB.1.8.1 Origin and Detection: NB.1.8.1 was first identified as a significant driver of rising COVID-19 cases in China. The U.S. Centers for Disease Control and Prevention (CDC) confirmed its presence in the United States, though as of late May 2025, fewer than 20 cases had been reported domestically. Global Spread: The World Health Organization (WHO) and multiple health authorities have noted that NB.1.8.1 is now spreading worldwide, with cases reported in several countries. Its rapid dissemination has raised concerns about potential increases in COVID-19 cases in various regions. 2. Variant Characteristics Genetic Profile: NB.1.8.1 is a subvariant of the Omicron lineage, featuring several mutations in the spike protein. These m...

Early treatment is critical and the most important factor in managing this disease. COVID-19 is a clinical diagnosis; a confirmed antigen or PCR test is not required. Treatment should be initiated immediately after the onset of flu-like symptoms. The multiple therapies and drugs in this protocol have different mechanisms of action and work synergistically during various phases of the disease. About I-CARE Protocol The information in this document is our recommended approach to COVID-19 based on the best (and most recent) literature. It is provided as guidance to healthcare providers worldwide on the early treatment of COVID-19. Patients should always consult with their provider before starting any medical treatment. Updates:  Ivermectin, Hydroxychloroquine Use Soared During COVID-19 Pandemic: 2025 Study 53,000+ Patient Study Finds Low-Dose Hydroxychloroquine Associated with Reduced COVID-19 Mortality in China (Frontiers of Medicine 2025) Note: highlighting his objectivity, while Pi...